Please login to the form below

Not currently logged in
Email:
Password:

Shire’s Dr Armin Reininger moves to Sobi

Appointed as senior vice president, head of global medical and scientific affairs

Sobi Dr Armin ReiningerStockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs.

Dr Reininger joins the rare diseases specialist from Shire, where he most recently served as head of medical affairs for haematology, EMEA at Baxalta, having first joined Baxter as head of global medical affairs for haemophilia.

Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University in Munich, Germany, The Scripps Research Institute, and Harvard Medical School.

Geoffrey McDonough, president and chief executive officer at Sobi, said: “We are truly delighted to welcome Armin to Sobi.

“Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in medical scientific affairs to our stakeholders.”

17th January 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics